Antipsychotic-Induced Hyperprolactinemia

Antipsychotic-induced hyperprolactinemia.

Use of antipsychotic agents has been associated with hyperprolactinemia, or elevated prolactin levels; this hormonal abnormality can interfere with the functioning of reproductive, endocrine, and metabolic systems. As antipsychotic agents are increasingly used for both United States Food and Drug Administration-approved and nonapproved indications, many individuals are at risk for developing an...

Antipsychotic-induced Hyperprolactinemia: Pathophysiology and Clinical Consequences

Hyperprolactinemia is one of the major adverse effects of antipsychotic agents. Although it is predominantly associated with the use of conventional or typical agents, atypical agents also cause varying degrees of hyperprolactinemia. Clinical manifestations, which tend to be underrecognized, are the result of the direct action of prolactin on its target tissues and of the sequelae of hypogonadi...

Reversal of symptomatic antipsychotic-induced hyperprolactinemia with addition of aripiprazole

Reversal of symptomatic antipsychotic-induced hyperprolactinemia with addition of aripiprazole Paraskevi Kotorki, Parthena Pelka, Christina Leotsakou, Aikaterini Kalogeropoulou, Markella Fiste, Georgios Vagionis, Anastasia Roussi, Periklis Paterakis From 1 International Congress on Neurobiology and Clinical Psychopharmacology and European Psychiatric Association Conference on Treatment Guidance...

PM403. Comparison between addition of and switching to aripiprazole for resolving antipsychotic-induced hyperprolactinemia

s | 47 scores. A linear regression analysis revealed that being male and married had significant positive associations with sexual arousal, sexual satisfaction, and/or sexual desire, while the presence of TD and a longer duration of illness were associated with poor sexual arousal and/or sexual desire. Additionally, sexual function was significantly associated with SWN-K and DAI scores in mult...

Reversal of antipsychotic-induced hyperprolactinemia, weight gain, and dyslipidemia by aripiprazole: A case report.